Welcome to Immunova, LLC

Immunova, LLC is a science-driven biopharmaceutical company dedicated to the discovery and development of next-generation...

Connect With Us

About Us

Immunova, LLC is a science-driven biopharmaceutical company dedicated to the discovery and development of next-generation lipid-based therapeutics.

We specialize in targeting underexplored pathological mechanisms to address some of the most challenging conditions in modern medicine.

Our Mission

Our mission is to advance the development of innovative lipid-based therapeutics to address complex neurological and metabolic diseases. Through cutting-edge research and scientific collaboration, we aim to transform discovery science into impactful clinical solutions.

Focus 1 (CNS Research)

AD / ADRD (Alzheimer's)
PD (Parkinson's)
Glioma

Focus 2 (Liver Metabolic)

Fatty Liver
HCC (Liver Cancer)
Obesity

Technology

Proprietary Lipid Ether Amides (LEA)
LEA Hybrids
Dopamine / Serotonin
GABA / Cysteine

Visualizing The Lea Hybrid Mechanism

To help visitors understand how your lipid-based therapeutics work, a diagram of a lipid nanoparticle or hybrid delivery system is essential.

Core Technology

Our LEA Hybrid technology integrates bioactive LEA with key neurotransmitters and metabolic compounds, enabling targeted therapeutic delivery and enhanced biological interaction.